Sibutramine in clinical practice
نویسندگان
چکیده
منابع مشابه
Frequency of Errors in Clinical Laboratory Practice
Background and Objective: Laboratory errors are one of the major factors that affect the diagnosis, prognosis, treatment and monitoring in patients.The objective of study is to evaluate the frequency and type of errors in different phases of testing at the Pathology Department of the Shalamar Hospital, Lahore and to evaluate the causes of errors. Methods: This observational study was carrie...
متن کاملSibutramine on Cardiovascular Outcome
S ibutramine, a combined norepinephrine and serotonin reuptake inhibitor, is effective in the management of obese patients requiring pharmacotherapy as part of a multimodal approach to weight loss. It improves insulin resistance markers, glucose metabolism, and atherogenic dyslipidemia in both diabetic and nondiabetic patients, most of these effects resulting fromweight loss. However, sibutrami...
متن کاملClinical Practice Guidelines: Principles for Clinical Practice
S5 print and electronic media where they come across lay guidelines; doctors need to inform the patients regarding available treatment alternatives, their potential harms and benefits, where clinical guidelines work as the best available educative tool. CPGs highlight gaps in known literature where treatment recommendations are not clear cut; hence it helps in identifying areas where future res...
متن کاملPhentermine, Sibutramine and Affective Disorders
A safe and effective way to control weight in patients with affective disorders is needed, and phentermine is a possible candidate. We performed a PubMed search of articles pertaining to phentermine, sibutramine, and affective disorders. We compared the studies of phentermine with those of sibutramine. The search yielded a small number of reports. Reports concerning phentermine and affective di...
متن کاملExposure to sibutramine during pregnancy.
QUESTION One of my patients who was taking sibutramine to lose weight found out that she had unexpectedly conceived. The medication was stopped as soon as she found out, about 5 weeks into the pregnancy. Is the baby at risk? Should the pregnancy be aborted? ANSWER No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Obesity
سال: 2001
ISSN: 0307-0565,1476-5497
DOI: 10.1038/sj.ijo.0801932